Esketamine, the nasal-spray antidepressant recently approved by the F.D.A., is promising, but using it entails some practical challenges.
Published: March 8, 2019 at 01:00AM
from NYT Health https://ift.tt/2CltqTt
Esketamine, the nasal-spray antidepressant recently approved by the F.D.A., is promising, but using it entails some practical challenges.
Published: March 8, 2019 at 01:00AM
from NYT Health https://ift.tt/2CltqTt